Our team discovered that cancer-originated DNA can promote the stimulation of ERK1/2 and MMP2/9 in HCC cells, while cotreatment with sinobine hydrochloride reduces the expression of ERK1/2 and MMP2/9. Here, MAPK3 is linked to cancer.